| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.009 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.091 | 0.009 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.009 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |